Purchase Enroflox 100 100 mg/ml 100 ml
For the treatment and control of bovine respiratory disease
during checkout
Purchase Enroflox 100 100 mg/ml 100 ml
For the treatment and control of bovine respiratory disease
during checkout
Product description
Enroflox 100 is an FDA-approved sterile, ready-to-use injectable antimicrobial solution that contains enrofloxacin, a broad-spectrum fluoroquinolone antimicrobial agent.
Active ingredients
Each Enroflox 100 mL contains:
- Enrofloxacin 100mg
Indications for use
Cattle:
Single-Dose Therapy (BRD Treatment):
- Enroflox 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle.
Multiple-Day Therapy (BRD Treatment):
- Enroflox 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni in beef and non-lactating dairy cattle.
Single-Dose Therapy (BRD Control in High-Risk Cattle):
- Enroflox 100 is approved for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with M. haemolytica, P.multocida, H. somni and M. bovis. Administer a single dose to cattle at high risk of BRD due to stresses including transportation, extreme environmental conditions and processing (e.g. castration, dehorning).
Swine:
-
Enroflox 100 works as a single-injection for pigs of all ages.
-
Enroflox 100 is indicated for the treatment and control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis, Streptococcus suis, Bordetella bronchiseptica and Mycoplasma hyopneumoniae.
-
Swine Respiratory Disease (SRD) is the prevalent cause of nursery pig and grower/finisher deaths.3 Primary and secondary bacterial pathogens include Actinobacillus pleuropneumoniae (APP), Pasteurella multocida, Haemophilus parasuis and Streptococcus suis. These infectious agents act together to increase the severity and duration of the disease.
-
Enroflox 100 is indicated for the control of colibacillosis in groups or pens of weaned pigs where colibacillosis associated with Escherichia coli has been diagnosed.
Administration and dosage
Cattle:
Single-Dose Therapy (BRD Treatment):
- Administer, by subcutaneous injection, a single dose of 7.5-12.5 mg/kg of body weight (3.4-5.7 mL/100 lb).
Multiple-Day Therapy (BRD Treatment):
-
Administer daily, a subcutaneous dose of 2.5-5 mg/kg of body weight (1.1-2.3mL/100 lb). Treatment should be repeated at 24-hour intervals for three days.
-
Additional treatments may be given on Days 4 and 5 to animals that have shown clinical improvement but not total recovery.
Single-Dose Therapy (BRD Control in High-Risk Cattle):
- Administer, by subcutaneous injection, a single dose of 7.5 mg/kg of body weight (3.4 mL/100 lb).
Swine:
- Enroflox 100 may be administered as a single intramuscular or SQ dose of 7.5 mg/kg of body weight (3.4 mL/100 lbs.)